Skip to content
back
back
back
back
back
You are about to leave Fidia Pharma USA Inc.
All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.
PROCEED
cta

NEWSROOM

Corporate
04/06/2024
Fidia Farmaceutici enters into definitive agreement for its most important acquisition ever and confirms a double-digit growth trend in 2023 
read more
Corporate
03/04/2024
Fidia obtains Certification for Gender Equality in Italy
read more
Corporate
05/06/2023
Fidia Farmaceutici, 11% growth in 2022: turnover of €412 million
read more
You are about to leave Fidia Pharma USA Inc.
All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.
PROCEED
cta